Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements 2024
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show 2025
Spring on the Road
Spring Wellness 2025
Canada Votes 2025
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
Ontario Votes
Auction 2025
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about INCY
Recent news which mentions INCY
< Previous
1
2
3
4
5
6
7
8
9
Next >
Expert Ratings for Incyte
September 21, 2023
Tickers
INCY
Tags
Analyst Ratings
Benzinga
BZI/AAR
From
Benzinga
3 Biotech Stocks That Should Be on Every Investor’s Radar This Fall
September 20, 2023
Tickers
EXEL
INCY
JAZZ
Tags
NASDAQ:JAZZ,NASDAQ:INCY,NASDAQ:EXEL
INCY
JAZZ
From
InvestorPlace
Anemia Advantage For GSK's Blood Cancer Therapy Could Influence Market Share Despite Incyte's Jakafi Comparison
September 18, 2023
Tickers
BMY
GSK
INCY
Tags
Benzinga
Trading Ideas
Markets
From
Benzinga
Analyst Ratings for Incyte
August 02, 2023
Tickers
INCY
Tags
INCY
Benzinga
Analyst Ratings
From
Benzinga
Incyte's Jakafi Patent Expiry In 2028 Poses Challenge, Analyst Says New Treatments To Battle For Market Share
August 01, 2023
Tickers
INCY
Tags
Benzinga
Trading Ideas
Health Care
From
Benzinga
Incyte's Earnings Outlook
July 31, 2023
Tickers
INCY
Tags
BZI/EP
Market News
Earnings
From
Benzinga
Cathie Wood's Ark Invest Buys Spotify, Iridium Shares — Trims Tesla, Coinbase Holdings
July 25, 2023
Tickers
ACCD
AIR
ARKQ
ARKW
Tags
ARKW
CCJ
INCY
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 25, 2023
July 25, 2023
Tickers
ABBV
AGLE
AI
AVNS
Tags
VRCA
PGR
MNSB
From
Benzinga
Syndax-Incyte Partnered Chronic Graft-Versus-Host Disease Achieves Primary Endpoint In Pivotal Trial, FDA Submission Planned By 2023 End
July 24, 2023
Tickers
INCY
SNDX
Tags
Market News
SNDX
Benzinga
From
Benzinga
'I Don't Want You To Touch That': Cramer Rejects Stock Down 32% Over Past Month, Prefers Tesla
July 19, 2023
Tickers
ARE
ASTS
CNC
FRT
Tags
TSLA
News
Small Cap
From
Benzinga
Incyte Skin Disease Drug Meets Primary Goal In Late-Stage Study In Children
July 12, 2023
Tickers
INCY
Tags
Biotech
INCY
News
From
Benzinga
Syndax Pharmaceuticals Set for Potential Breakthrough with Revumenib: Analyst Calls It 'Potentially Best-In-Class' In Competitive Landscape
July 11, 2023
Tickers
INCY
SNDX
Tags
General
Briefs
SNDX
From
Benzinga
2 Low-Priced Stocks That Could Make You Richer
June 26, 2023
Tickers
ACRS
AGEN
AXSM
BMY
Tags
VKTX
Market News
AGEN
From
Motley Fool
The bull market has left these 20 companies behind, but they are primed for growth
June 13, 2023
Tickers
AAPL
AMZN
BLK
CI
Tags
CI
TECH
PODD
From
MarketWatch
Benzinga's Top Ratings Upgrades, Downgrades For May 4, 2023
May 04, 2023
Tickers
ABSI
BLDR
BLKB
CERE
Tags
FULC
WIX
RBA
From
Benzinga
Why Incyte Shares Are Falling Today
May 02, 2023
Tickers
INCY
Tags
Hedge Funds
General
Movers
From
Benzinga
Earnings Outlook For Incyte
May 01, 2023
Tickers
INCY
Tags
Benzinga
Earnings
Market News
From
Benzinga
What To Expect When Incyte Reports Q1 Earnings In Almost Two Weeks
April 21, 2023
Tickers
CTIC
INCY
Tags
General
Briefs
Market News
From
Benzinga
7 Biotech Stocks That Could Cure Your Portfolio Woes
April 19, 2023
Tickers
ARGX
BGNE
BMRN
INCY
Tags
ARGX
UTHR
LEGN
From
InvestorPlace
Ominous Death Cross Forms On Incyte's Chart
April 13, 2023
Tickers
INCY
Tags
Market News
BZI/CROSS
Trading Ideas
From
Benzinga
Incyte Faces Increased Competition From Emerging JAK Inhibitors, RBC Capital Lowers Price Target
April 10, 2023
Tickers
INCY
Tags
Brian Abrahams
INCY
Analyst Ratings
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 10, 2023
April 10, 2023
Tickers
AMH
AVB
BBWI
BCE
Tags
AVB
Market News
XMTR
From
Benzinga
Valero Energy To Rally 32%? Here Are 10 Other Analyst Forecasts For Monday
April 10, 2023
Tickers
BA
CLNN
CTLT
CWK
Tags
WY
Market News
BA
From
Benzinga
What 13 Analyst Ratings Have To Say About Incyte
March 28, 2023
Tickers
INCY
Tags
INCY
BZI/AAR
Market News
From
Benzinga
Second Setback For Incyte's LIMBER Program - Analyst Says 'Resolution Timelines Unclear To Assess Impact'
March 24, 2023
Tickers
INCY
Tags
why it's moving
Biotech
INCY
From
Benzinga
Incyte Would Now Compete With Merck, Pfizer As Its Skin Cancer Treatment Scores FDA Accelerated Approval
March 23, 2023
Tickers
INCY
MGNX
MKGAF
MKKGY
Tags
INCY
Biotech
MKGAF
From
Benzinga
7 Healthcare Stocks to Buy for Long-Term Growth and Stability
March 21, 2023
Tickers
BIIB
ESALY
HRMY
INCY
Tags
ESALY
INCY
MCK
From
InvestorPlace
Why Shares of MacroGenics Climbed Thursday
March 16, 2023
Tickers
INCY
MGNX
PRVB
Tags
Market News
PRVB
Recent Press Releases
From
Motley Fool
Analyst Expectations for Incyte's Future
March 07, 2023
Tickers
INCY
Tags
INCY
Market News
BZI/AAR
From
Benzinga
Incyte Discontinues LIMBER-304 On Doubts Regarding Meeting Primary Goal, Analyst Says It Underpins Some Investor Concerns
March 06, 2023
Tickers
INCY
Tags
Briefs
General
Health Care
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.
